Abstract
Expression of oncogenic v-H-Ras in the thyroid cell line FRTL-5 (FRTL-5Ras) results in uncontrolled proliferation, loss of thyroid-specific gene expression and tumorigenicity. Concomitant expression of constitutively activated MEK and Rac, two major H-Ras downstream effectors, in FRTL-5 (FRTL-5MEK/Rac) recapitulates H-Ras effects on proliferation and morphology. In contrast to FRTL-5Ras, however, FRTL-5MEK/Rac cells remain differentiated and are not tumorigenic. To find H-Ras induced genes potentially responsible for tumorigenicity and loss of differentiation, we have used subtractive suppression hybridization (SSH), a PCR-based cDNA subtraction technique, between de-differentiated and tumorigenic FRTL-5Ras cells and differentiated and non-tumorigenic FRTL-5MEK/Rac cells. We examined 800 of the cDNA clones obtained after subtraction and verified their levels of expression in the two cell lines by reverse northern, identifying 337 H-Ras induced genes. By sequence analysis, we clustered 57 different genes. Among these, 39 were known genes (involved in diverse signal transduction processes regulating mitogenic activity, cell survival, cytoskeletal reorganization, stress response and invasion) while the remaining 18 clones were novel genes. Among the 57 H-Ras specific clones, we identified those genes whose expression is induced early by H-Ras. We suggest that these immediate-early genes may play a crucial role in H-Ras-mediated transformation in thyroid epithelial cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ambesi-Impiombato FS, Picone R, Tramontano D . 1982 Cold Spring Harbour Conferences on Cell Proliferation (9: Growth of Cells in Hormonally Defined Media) pp. 483–492
Augenlicht LH . 1987 Cancer Res. 47: 6017–6021
Bos JL . 1989 Cancer Res. 49: 4682–4689
Cartwright P, Muller H, Wagener C, Holm K, Helin K . 1998 Oncogene 17: 611–623
Cass LA, Meinkoth JL . 2000 Oncogene 19: 924–932
Church GM, Gilbert W . 1984 Proc. Natl. Acad. Sci. USA 81: 1991–1995
Ciccarelli FD, Acciarito A, Alberti S . 2000 Hum. Mol. Genet. 12: 1001–1007
Cobellis G, Missero C, Di Lauro R . 1998 Oncogene 17: 2047–2057
Cowley S, Paterson H, Kemp P, Marshall CJ . 1994 Cell 77: 841–852
Damante G, Di Lauro R . 1994 BBA 1218: 255–266
Datta SR, Brunet A, Greenberg ME . 1999 Genes Dev. 13: 2905–2927
Diatchenko L, Chris Lau Y-F, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukianov K, Gurskaya N, Sverdlov ED, Siebert PD . 1996 Proc. Natl. Acad. Sci. USA 93: 6025–6030
Farid NR, Shi Y, Zou M . 1994 Endocr. Rev. 15: 202–232
Francis-Lang H, Zannini MS, De Felice M, Berlingieri MT, Fusco A, Di Lauro R . 1992 Mol. Cell. Biol. 12: 5793–5800
Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vecchio G . 1987 Mol. Cell. Biol. 7: 3365–3370
Gaubatz S, Wood JG, Livingston DM . 1998 Proc. Natl. Acad. Sci. USA 95: 9190–9195
Groundine M, Weintraub H . 1980 Proc. Acad. Natl. Sci. USA 77: 5351–5354
He T-C, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B . 1998 Proc. Natl. Acad. Sci. USA 95: 2509–2514
Khosravi-Far R, Campbell S, Rossman KL, Der CJ . 1998 Adv. Cancer Res. 72: 57–107
Langnaese K, Beesley PW, Gundelfinger ED . 1997 J. Biol. Chem. 272: 821–827
Malumbres M, Pellicer A . 1998 Front. Biosci. 3: 887–912
Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG . 1994 Science 265: 966–970
Missero C, Cobellis G, De Felice M, Di Lauro R . 1998 Mol. Cell. Endocr. 140: 37–43
Missero C, Pirro MT, Di Lauro R . 2000 Mol. Cell. Biol. 20: 2783–2793
Nobes CD, Hall A . 1995 Cell 81: 53–62
Qiu R-G, Chen J, Kirn D, McCormick F, Symons M . 1995 Nature 374: 457–459
Ridley AJ, Hall A . 1992 Cell 70: 389–399
Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A . 1992 Cell 70: 401–410
Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J . 1994 Nature 370: 527–532
Rodriguez-Viciana P, Warne P, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J . 1997 Cell 89: 457–467
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ . 2000 Trends Cell Biol. 10: 147–154
Sutton G, White O, Adams M, Kerlavage A . 1995 Genome Sci. Technol. 1: 9–19
Trimarchi JM, Fairchild B, Verona R, Moberg K, Andon N, Lees JA . 1998 Proc. Natl. Acad. Sci. USA 95: 2850–2855
Uwabe K, Gahara Y, Yamada H, Miyake T, Kitamura T . 1997 Neuroscience 80: 501–509
White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M, Wigler MH . 1995 Cell 80: 533–541
Yoshimura T, Takeya M, Takahashi K . 1991 Biochem. Biophys. Res. Commun. 174: 504–509
Zuber J, Tchernitsa OI, Hinzmann B, Schmitz A-C, Grips M, Hellriegel M, Sers C, Rosenthal A, Schafer R . 2000 Nature Genetics 24: 144–152
Acknowledgements
We are grateful to Dr Mario De Felice, Dr Jong-Tai Chun and Dr Gabriella De Vita for critical reading of the manuscript. We are indebted to Dr Elio Biffali, Raimondo Pannone and Michele Pischetola for technical assistance. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC), the Consiglio Nazionale delle Ricerche ‘Target Project on Biotechnology’, the Ministero per I'Universita’ e la Ricerca Scientifica Project ‘Meccanismi molecolari responsabili del differenziamento delle cellule tiroidee e loro utilizzazione in diagnostica e terapia', and the Programma Biotecnologie legge 95/95 (MURST 5%).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cobellis, G., Missero, C., Simionati, B. et al. Immediate early genes induced by H-Ras in thyroid cells. Oncogene 20, 2281–2290 (2001). https://doi.org/10.1038/sj.onc.1204320
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204320